Search references for BIONTECH. Phrases containing BIONTECH
See searches and references containing BIONTECH!BIONTECH
German biotechnology company
BioNTech SE (/biːˈɒntɛk/ bee-ON-tek; or /baɪˈɒntɛk/ bye-ON-tek short for Biopharmaceutical New Technologies) is a German multinational biotechnology company
BioNTech
Type of vaccine for humans
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company
Pfizer–BioNTech COVID-19 vaccine
Pfizer–BioNTech_COVID-19_vaccine
regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin
List of COVID-19 vaccine authorizations
List_of_COVID-19_vaccine_authorizations
US program to accelerate COVID-19 vaccine efforts
development and production capacity of the Pfizer–BioNTech COVID-19 vaccine. On November 9, the Pfizer–BioNTech partnership announced positive early results
Operation_Warp_Speed
German oncologist and immunologist (born 1965)
researcher, entrepreneur, and businessman. He is the co-founder and CEO of BioNTech, which developed the world’s first mRNA-based vaccine against COVID-19
Uğur_Şahin
German physician and scientist (born 1967)
scientist and entrepreneur. In 2008, she co-founded the biotechnology company BioNTech, which in 2020 developed the first messenger RNA-based vaccine approved
Özlem_Türeci
Type of vaccine
the genomic DNA. While some messenger RNA vaccines, such as the Pfizer–BioNTech COVID-19 vaccine, have the disadvantage of requiring ultracold storage
MRNA_vaccine
American multinational pharmaceutical and biotechnology corporation
billion in 2025 revenues, 10% of total revenues), Comirnaty (the Pfizer–BioNTech COVID-19 vaccine) ($4.4 billion in 2025 revenues, 7% of total revenues)
Pfizer
Pandemic caused by SARS-CoV-2
Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm BIBP Sputnik V Variants Variants of concern Alpha Beta Gamma
COVID-19_pandemic
Vice President of the United States from 2017 to 2021
in at least 20 states. On December 18, the Pences received the Pfizer/BioNTech COVID-19 vaccine for SARS-CoV-2, in front of a live audience at a televised
Mike_Pence
Hungarian-American biochemist (born 1955)
associated with BioNTech RNA Pharmaceuticals, first as a vice president and promoted to senior vice president in 2019. In 2022, she left BioNTech to devote
Katalin_Karikó
Turkic ethnic group
first in the sciences. Immunologists Uğur Şahin and Özlem Türeci founded BioNTech, which is the company that developed one of the first efficacious vaccines
Turkish_people
Plan to immunize against COVID-19 in South Africa
Janssen (Johnson & Johnson), Pfizer-BioNTech and Oxford-AstraZeneca, administering both Janssen and Pfizer-BioNTech, with the Oxford-AstraZeneca vaccine
COVID-19 vaccination in South Africa
COVID-19_vaccination_in_South_Africa
RNA COVID-19 vaccine
respiratory virus vaccine, and it is similar to the efficacy of the Pfizer–BioNTech COVID-19 vaccine. Efficacy estimates were similar across age groups, sexes
Moderna_COVID-19_vaccine
Calendar year
begin mass vaccination with the Pfizer–BioNTech COVID-19 vaccine. In addition, Singapore approves the Pfizer–BioNTech COVID-19 vaccine, with other companies
2020
French chemist, pharmacist and microbiologist (1822–1895)
EpiVacCorona† Janssen Kostaive Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory
Louis_Pasteur
Taiwanese semiconductor foundry company
technology manufacturers had reached an agreement to purchase 10 million BioNTech COVID-19 vaccines from Germany. TSMC and Foxconn pledged to each buy five
TSMC
Vaccine against SARS-CoV-2
effective mRNA vaccines against COVID‑19. Major vaccines include the Pfizer–BioNTech mRNA vaccine, Moderna mRNA vaccine, and the Novavax protein subunit vaccine
COVID-19_vaccine
Private university in Hanover, New Hampshire, US
Elizabeth Prize for his work on imaging sensor technology. The Pfizer–BioNTech COVID-19 vaccine, which was approved in 2021, was based on findings that
Dartmouth_College
Immunisation against COVID-19
two of the Pfizer–BioNTech COVID-19 vaccine. There are three vaccines currently in use; following approval of the Pfizer–BioNTech COVID-19 vaccine (Comirnaty)
COVID-19 vaccination in the United Kingdom
COVID-19_vaccination_in_the_United_Kingdom
CEO of Pfizer (born 1961)
2022 Genesis Prize for his leadership in the development of the Pfizer–BioNTech COVID-19 vaccine. Bourla was born and raised in Thessaloniki, Greece. His
Albert_Bourla
Study of health and disease within a population
EpiVacCorona† Janssen Kostaive Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory
Epidemiology
Scientific work to develop a vaccine for COVID-19
had been distributed for use outside of the phase 3 trial. The Pfizer–BioNTech partnership submitted an Emergency Use Authorization (EUA) request to the
History of COVID-19 vaccine development
History_of_COVID-19_vaccine_development
Study of the production and behaviour of materials at very low temperatures
Retrieved 11 June 2015. "Pfizer–BioNTech COVID-19 Vaccine Vaccination Storage & Dry Ice Safety Handling". Pfizer-BioNTech. Archived from the original on
Cryogenics
Federal agency of the United States Department of Health and Human Services
drudis.2020.11.025. PMC 7694556. PMID 33253920. "Comirnaty and Pfizer-BioNTech COVID-19 Vaccine". FDA. January 3, 2022. Archived from the original on
Food_and_Drug_Administration
Contagious disease caused by SARS-CoV-2
treatments or a vaccine become available. Major vaccines include the Pfizer–BioNTech mRNA vaccine, Moderna mRNA vaccine, and the Novavax protein subunit vaccine
COVID-19
False or misleading virus information
Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm BIBP Sputnik V Variants Variants of concern Alpha Beta Gamma
COVID-19_misinformation
American physician and immunologist (born 1959)
mRNA vaccines, the best known of which are those for COVID-19 produced by BioNTech/Pfizer and Moderna. With biochemist Katalin Karikó, Weissman received the
Drew_Weissman
Ireland 70 Struengmann Andreas Struengmann, Thomas Struengmann 19.6 (2024) BioNTech Germany 71 Reuben David Reuben, Simon Reuben 19.2 (2024) Real estate, financial
List_of_wealthiest_families
Virus that causes COVID-19
Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm BIBP Sputnik V Variants Variants of concern Alpha Beta Gamma
SARS-CoV-2
been unlawfully accessed after a cyberattack on the EMA. BioNTech also said that "No BioNTech or Pfizer systems have been breached in connection with this
European Medicines Agency data breach
European_Medicines_Agency_data_breach
Prime Minister of New Zealand from 2017 to 2023
and its Pacific partners in addition to the existing stocks from Pfizer/BioNTech and Janssen Pharmaceutica. On 26 January 2021, Ardern stated that New Zealand's
Jacinda_Ardern
American biotechnology company
legal cases between Moderna and Pfizer and BioNTech in various countries, alleging that the Pfizer–BioNTech COVID-19 vaccine violates the patent on Moderna's
Moderna
Topics referred to by the same term
Bridge and tunnel, a pejorative term for commuters into Manhattan, New York BioNTech, a German biotechnology company Brand New Theatre, an American student
BNT_(disambiguation)
Chemical compound
PEGylated lipid is used as an excipient in both the Moderna and Pfizer–BioNTech vaccines for SARS-CoV-2. Both RNA vaccines consist of messenger RNA, or
Polyethylene_glycol
President of the European Commission since 2019
close a deal worth €35 billion to provide 900 million doses of the Pfizer–BioNTech COVID-19 vaccine with an additional 900 million doses available for purchase
Ursula_von_der_Leyen
Plan to immunize against COVID-19
all seven vaccines included in the European portfolio - Moderna, Pfizer-BioNTech, Oxford–AstraZeneca, Sanofi, CureVac, Novavax, and Janssen, even though
COVID-19 vaccination in Bulgaria
COVID-19_vaccination_in_Bulgaria
Immunisation programme against COVID-19 in Africa
Bank to address the health and economic impact of COVID-19. Meanwhile, BioNTech and the European Union are collaborating to assess mRNA vaccine production
COVID-19 vaccination in Africa
COVID-19_vaccination_in_Africa
Ongoing COVID-19 vaccine program in Australia
Administration (TGA) approved four vaccines for Australian use in 2021: the Pfizer–BioNTech vaccine on 25 January, the Oxford–AstraZeneca vaccine on 16 February, Janssen
COVID-19 vaccination in Australia
COVID-19_vaccination_in_Australia
Russian vaccine against COVID-19
continuous "colder chain" or cold-chain storage – as required for the Pfizer–BioNTech and Moderna vaccines – and allowing transportation to remote locations
Sputnik_V_COVID-19_vaccine
Plan to immunize against COVID-19
Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, and mass vaccinations began four days later
COVID-19 vaccination in the United States
COVID-19_vaccination_in_the_United_States
Medicine and therapeutic regulatory agency of the Australian Government
On 25 January 2021, the TGA provisionally approved the two-dose Pfizer–BioNTech COVID-19 vaccine, named COMIRNATY, for use within Australia. The provisional
Therapeutic Goods Administration
Therapeutic_Goods_Administration
Chairperson of the TSMC Charity Foundation (born 1944)
Taiwan. Later that year, TSMC jointly donated 15 million doses of the BioNTech (BNT) vaccine to Taiwan with Foxconn, the Yongling Foundation, and the
Sophie_Chang_(philanthropist)
approved the Pfizer-BioNTech vaccine for adolescents aged 12 to 15. On August 23, 2021, the FDA granted full approval to the Pfizer–BioNTech vaccine for individuals
COVID-19 pandemic in the United States
COVID-19_pandemic_in_the_United_States
Variant of the SARS-CoV-2 virus
African Health Products Regulatory Authority (SAHPRA) approved the Pfizer-BioNTech vaccine (BNT162b2) for section 21 Emergency Use Authorisation. On 1 April
SARS-CoV-2_Beta_variant
vaccine arrived in Australia as more than 142,000 doses of the Pfizer/BioNTech COVID-19 vaccine touched down at Sydney Airport; Tabloid media reported
List of The Weekly with Charlie Pickering episodes
List_of_The_Weekly_with_Charlie_Pickering_episodes
Chinese multinational holding company
partnered with German biotech firm Biopharmaceutical New Technologies (BioNTech) to produce and distribute the COVID-19 mRNA vaccine BNT162b2. The company
Fosun_International
Chemical compound
attracted attention as a component of the SARS-CoV-2 vaccine, BNT162b2, from BioNTech and Pfizer. Specifically, it is one of four components that form lipid
ALC-0315
Tunisian artificial intelligence company
Karim Beguir and Zohra Slim. It is based in London and is a subsidiary of BioNTech. The company is particularly known for developing an early warning system
InstaDeep
Plan to immunize against COVID-19
Muhyiddin Yassin became the first individual in Malaysia to receive the Pfizer–BioNTech COVID-19 vaccine, in a broadcast that was aired live nationwide. As of
COVID-19 vaccination in Malaysia
COVID-19_vaccination_in_Malaysia
Preparation for acquired immunity to disease
emergency use authorization in some countries. For example, the Pfizer-BioNTech vaccine and Moderna mRNA vaccine are approved for use in adults and children
Vaccine
Infectious disease caused by Borrelia bacteria, spread by ticks
EpiVacCorona† Janssen Kostaive Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory
Lyme_disease
Spanish politician (born 1966)
Agency approved the use of the first of the vaccines, the one developed by BioNTech and Pfizer. The first doses arrived in Spain and the rest of the member
Salvador_Illa
Phase of clinical research in medicine
EpiVacCorona† Janssen Kostaive Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory
Clinical_trial
Former method of smallpox immunisation
EpiVacCorona† Janssen Kostaive Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory
Variolation
Chemical compound
deployed in the Pfizer-BioNTech SARS-CoV-2 mRNA vaccine (0.05 mg per dose) that contains the active ingredient tozinameran. Pfizer–BioNTech COVID-19 vaccine
ALC-0159
American immunologist (born 1940)
first Western country to license a vaccine against the coronavirus (Pfizer-BioNTech). In response, Fauci said that the U.S. Food and Drug Administration (FDA)
Anthony_Fauci
Agency of the European Union
pharmaceutical products. While in the process of evaluating the Pfizer–BioNTech COVID-19 vaccine in December 2020, the EMA suffered a cyberattack, resulting
European_Medicines_Agency
Novel drug delivery system
nanoparticles as their delivery vehicle (including both the Moderna and the Pfizer–BioNTech COVID-19 vaccines). A lipid nanoparticle is typically spherical with an
Lipid-based_nanoparticle
Invasion of an organism's body by pathogenic agents
EpiVacCorona† Janssen Kostaive Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory
Infection
Administration (FDA) approved Emergency Use Authorization (EUA) for Pfizer–BioNTech COVID-19 vaccine roll-out. This is the first EUA granted in the country
Timeline of the COVID-19 pandemic in the Philippines (2021)
Timeline_of_the_COVID-19_pandemic_in_the_Philippines_(2021)
Anti-vaccination myth
laboratory mouse dying of lymphoma after being injected with the Pfizer–BioNTech COVID-19 vaccine was claimed to prove the existence of turbo cancer. However
Turbo_cancer
Dispute between the European Union and AstraZeneca
second vaccine to enter the national rollout programme, joining the Pfizer–BioNTech vaccine which had been approved on 2 December 2020. AstraZeneca submitted
European Commission–AstraZeneca COVID-19 vaccine dispute
European_Commission–AstraZeneca_COVID-19_vaccine_dispute
German scientist
conjugate vaccine (Prevnar), and is working with BioNTech to create a COVID-19 vaccine using mRNA (Pfizer–BioNTech COVID-19 vaccine) that was approved for Emergency
Kathrin_Jansen
State of Mexico
state health department reported that the first 9,759 doses of the Pfizer–BioNTech COVID-19 vaccine arrived in the state for application in health workers
Morelos
Misinformation about contagious disease
CGTN and the Global Times, raised doubts about the efficacy of the Pfizer–BioNTech vaccine, calling for an investigation into the deaths of elderly people
COVID-19 misinformation by China
COVID-19_misinformation_by_China
Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm BIBP Sputnik V Variants Variants of concern Alpha Beta Gamma
National responses to the COVID-19 pandemic
National_responses_to_the_COVID-19_pandemic
688235 33.14 (Nov 2021) 34.20 27.00 26.00 24.03 10.28 8.33 4.45 1.20 35 1 BioNTech[P] GER NSE: BNTX 44.07 62.52 19.62 7.68 - 36 1 Horizon Therapeutics[P]
List of largest biomedical companies by market capitalization
List_of_largest_biomedical_companies_by_market_capitalization
German multinational pharmaceutical and biotechnology company
2026, Bayer's Monsanto filed patent infringement lawsuits against Pfizer, BioNTech and Moderna over technology used in the manufacture of their COVID-19 vaccines
Bayer
Health control procedure against COVID-19
Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm BIBP Sputnik V Variants Variants of concern Alpha Beta Gamma
Face masks during the COVID-19 pandemic
Face_masks_during_the_COVID-19_pandemic
Vaccine for mpox
EpiVacCorona† Janssen Kostaive Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory
Mpox_vaccine
Vaccine against SARS-CoV-2
primary vaccination series and a booster following first dose with Pfizer–BioNTech COVID-19 vaccine. The study is being partially funded by a grant from the
Zapomeran
Chinese pharmaceutical company
BNT162b2 On 17 March 2020, BioNTech received a $135 million investment from Fosun in exchange for 1.58 million shares in BioNTech and the future development
Fosun_Pharma
Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm BIBP Sputnik V Variants Variants of concern Alpha Beta Gamma
COVID-19 pandemic on cruise ships
COVID-19_pandemic_on_cruise_ships
COVID-19 vaccination programme in Canada
the Pfizer-BioNTech and Moderna vaccines for use as booster (or third doses). On November 19, 2021, Health Canada approved the Pfizer-BioNTech vaccine (with
COVID-19 vaccination in Canada
COVID-19_vaccination_in_Canada
Pharmaceutical compound
EpiVacCorona† Janssen Kostaive Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory
UroVaxom
Ongoing COVID-19 viral pandemic in Bulgaria
taking place simultaneously in Sofia, Plovdiv and Bourgas. The Pfizer-BioNTech vaccine was the first to be administered; recipients on the opening day
COVID-19_pandemic_in_Bulgaria
American biotechnology company
February 2022, as the fifth vaccine against COVID-19, following Pfizer/BioNTech, Moderna, Janssen and AstraZeneca. On 1 November 2021, Novavax and Serum
Novavax
Andreas Strüngmann Germany 9.8 billion Hexal, BioNTech 232 Thomas Strüngmann Germany 9.8 billion Hexal, BioNTech 256 Ludwig Merckle Germany 9.4 billion Phoenix
List_of_Germans_by_net_worth
Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm BIBP Sputnik V Variants Variants of concern Alpha Beta Gamma
List of deaths due to the COVID-19 pandemic
List_of_deaths_due_to_the_COVID-19_pandemic
Clinical research to establish the characteristics of COVID-19 vaccines
authority for public use: one DNA vaccine: ZyCoV-D four RNA vaccines: Pfizer–BioNTech, Moderna, Walvax, and Gemcovac twelve inactivated vaccines: Chinese Academy
COVID-19 vaccine clinical research
COVID-19_vaccine_clinical_research
Misinformation regarding the SARS-CoV-2 vaccine and the resulting hesitancy towards it
study in the New England Journal of Medicine reported that the Pfizer–BioNTech COVID-19 vaccine was 88 percent effective in preventing symptomatic infections
COVID-19 vaccine misinformation and hesitancy
COVID-19_vaccine_misinformation_and_hesitancy
Immunisation programme against COVID-19 in Botswana
UNICEF Botswana. On 3 June Botswana received 19,890 doses of the Pfizer-BioNTech vaccine through COVAX. A supply agreement with Moderna was announced
COVID-19 vaccination in Botswana
COVID-19_vaccination_in_Botswana
EpiVacCorona† Janssen Kostaive Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory
Timeline_of_human_vaccines
Sequence of major events in a virus pandemic
Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm BIBP Sputnik V Variants Variants of concern Alpha Beta Gamma
Timeline of the COVID-19 pandemic in January 2020
Timeline_of_the_COVID-19_pandemic_in_January_2020
Distribution and administration of COVID-19 vaccinations
expressed concern over the short shelf-life of the Moderna and Pfizer-BioNTech vaccines, which expire within hours after being removed from the freezer;
Deployment of COVID-19 vaccines
Deployment_of_COVID-19_vaccines
Vaccine that uses a weakened form of the germ
EpiVacCorona† Janssen Kostaive Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory
Attenuated_vaccine
State in Germany
two important pharmaceutical companies, both near the border with Hesse: BioNTech(HQ), in Mainz, which developed the first mRNA vaccine against COVID-19
Hesse
Indonesia (BPOM) published an emergency use authorization for the Pfizer–BioNTech vaccine. 1.5 million doses of the Moderna vaccine and 1.16 million doses
Timeline of the COVID-19 pandemic in Indonesia (2021)
Timeline_of_the_COVID-19_pandemic_in_Indonesia_(2021)
Disease caused by C. difficile bacteria
EpiVacCorona† Janssen Kostaive Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory
Clostridioides difficile infection
Clostridioides_difficile_infection
Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm BIBP Sputnik V Variants Variants of concern Alpha Beta Gamma
Timeline of the COVID-19 pandemic
Timeline_of_the_COVID-19_pandemic
EpiVacCorona† Janssen Kostaive Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory
Anti-vaccine_activism
English physician (1749–1823)
EpiVacCorona† Janssen Kostaive Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory
Edward_Jenner
Ground and express delivery company
DHL entered agreements to deliver the COVID-19 vaccine manufactured by BioNTech and Pfizer. In March 2021, DHL Aviation announced the relocation of hub
DHL
Administration of a vaccine to protect against disease
EpiVacCorona† Janssen Kostaive Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory
Vaccination
737-7JW JY[citation needed] First Virtual Air II LLC 737-7JY JZ Pfizer-BioNTech Airlift Division 737-7JZ KB Qatar Amiri Flight 737-8KB 747-8KB KF Okay
List_of_Boeing_customer_codes
German billionaire investor, businessman, and entrepreneur
capital increase at Conergy. Also in 2008, the Strüngmann brothers supported BioNTech with a €136.5 million seed investment in a €150 million round that enabled
Thomas_Strüngmann
Swiss multinational pharmaceutical corporation
to preserve sales of Lucentis over a cheaper drug. Also in September, BioNTech has leased a large production facility from Novartis to follow all advance
Novartis
Current stage of COVID-19 disease
Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm BIBP Sputnik V Variants Variants of concern Alpha Beta Gamma
Endemic_COVID-19
Plan to immunize against COVID-19
274,950 doses of the Pfizer–BioNTech vaccine arrived in Indonesia. On 16 September, 2.5 million doses of the Pfizer–BioNTech vaccine and 968,360 doses of
COVID-19 vaccination in Indonesia
COVID-19_vaccination_in_Indonesia
travel, tourism, insurance
BIONTECH
BIONTECH
BIONTECH
BIONTECH
BIONTECH
BIONTECH
BIONTECH
BIONTECH
BIONTECH
travel, tourism, insurance